A Review: Genetic Mutations as a Key to Unlocking Drug Resistance in Cervical Cancer
Cervical cancer is the fourth most common cancer in women. Advanced stage and metastatic disease are often associated with poor clinical outcomes. This substantiates the absolute necessity for high-throughput diagnostic and treatment platforms that are patient and tumour specific. Cervical cancer tr...
| Published in: | Cancer Control |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2024-06-01
|
| Online Access: | https://doi.org/10.1177/10732748241261539 |